首页> 外文期刊>Der Pharmacia Lettre >Development and in vitro evaluation of gastroretentive drug delivery system of Losartan Potassium
【24h】

Development and in vitro evaluation of gastroretentive drug delivery system of Losartan Potassium

机译:氯沙坦钾胃肠保留药物递送系统的开发和体外评价

获取原文
           

摘要

In the present study, development of Gastroretentive Drug Delivery System (GRDDS) of Losartan potassium, an anti-hypertensive drug was designed to increase the gastric residence time. Formulations were prepared using wet granulation method, employing polymers like HPMC K4M, HPMC K15M, carbopol 934P and sodium alginate. Sodium bicarbonate and citric acid were used as gas generating agents. Tablets were evaluated for various parameters like hardness, friability, uniformity of weight, drug content uniformity, drug polymer interaction studies, swelling index, in vitro floating studies, In vitro drug release and short term stability studies. Drug release analysis on the basis of Higuchi-Korsmeyer model indicated that diffusion is the predominant mechanism controlling the drug release. The drug polymer interaction studies indicated no interaction. The short term stability study showed no significant change.
机译:在本研究中,设计一种抗高血压药物洛沙坦钾的胃滞留药物递送系统(GRDDS),以增加其在胃中的停留时间。通过湿法制粒方法,使用诸如HPMC K4M,HPMC K15M,carbopol 934P和藻酸钠的聚合物来制备制剂。碳酸氢钠和柠檬酸用作气体发生剂。评价片剂的各种参数,例如硬度,易碎性,重量均匀性,药物含量均匀性,药物聚合物相互作用研究,溶胀指数,体外漂浮研究,体外药物释放和短期稳定性研究。基于Higuchi-Korsmeyer模型的药物释放分析表明,扩散是控制药物释放的主要机制。药物聚合物相互作用研究表明没有相互作用。短期稳定性研究显示无明显变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号